APO Research
Talk to an analyst

APO RESEARCH · REPORT

NK1 Receptor Antagonist

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global NK1 Receptor Antagonist Industry Growth and Trends Forecast to 2032

23 December 2025104 pages

Choose your research edition.

Industry ResearchNK1 Receptor Antagonist Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal NK1 Receptor Antagonist Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal NK1 Receptor Antagonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NK1 Receptor Antagonist Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal NK1 Receptor Antagonist Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global NK1 Receptor Antagonist market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for NK1 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for NK1 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NK1 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the NK1 Receptor Antagonist market include Glenmark, Heron Therapeutics, TerSera Therapeutics, Torrent Pharmaceuticals, Beijing Sihuan Pharmaceutical, Fresenius Kabi, Hansoh Pharma, Helsinn Healthcare and Jiangsu Hengrui Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global NK1 Receptor Antagonist market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The NK1 Receptor Antagonist market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global NK1 Receptor Antagonist market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to NK1 Receptor Antagonist.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global NK1 Receptor Antagonist market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

NK1 Receptor Antagonist Market by Company

Glenmark

Heron Therapeutics

TerSera Therapeutics

Torrent Pharmaceuticals

Beijing Sihuan Pharmaceutical

Fresenius Kabi

Hansoh Pharma

Helsinn Healthcare

Jiangsu Hengrui Pharmaceuticals

Luoxin Pharmaceutical

Merck

Qilu Pharmaceutical

Yichang Humanwell Pharmaceutical

Chia Tai Tianqing Pharmaceutical

NK1 Receptor Antagonist Segment by Type

Netupitant

Maropitant

Rolapitant

Fosaprepitant

Aprepitant

Other

NK1 Receptor Antagonist Segment by Application

Hospital

Specialty Clinic

NK1 Receptor Antagonist Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK1 Receptor Antagonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NK1 Receptor Antagonist and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK1 Receptor Antagonist.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of NK1 Receptor Antagonist companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global NK1 Receptor Antagonist Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global NK1 Receptor Antagonist Market Size by Region (2021-2026) & (US$ Million) Table 3. Global NK1 Receptor Antagonist Market Share by Region (2021-2026) Table 4. Global NK1 Receptor Antagonist Market Size by Region (2027-2032) & (US$ Million) Table 5. Global NK1 Receptor Antagonist Market Share by Region (2027-2032) Table 6. Global NK1 Receptor Antagonist Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global NK1 Receptor Antagonist Market Size by Type (2021-2026) & (US$ Million) Table 8. Global NK1 Receptor Antagonist Market Size Share by Type (2021-2026) Table 9. Global NK1 Receptor Antagonist Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global NK1 Receptor Antagonist Market Size Share Forecasted by Type (2027-2032) Table 11. North America NK1 Receptor Antagonist Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America NK1 Receptor Antagonist Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe NK1 Receptor Antagonist Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe NK1 Receptor Antagonist Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific NK1 Receptor Antagonist Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific NK1 Receptor Antagonist Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America NK1 Receptor Antagonist Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America NK1 Receptor Antagonist Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa NK1 Receptor Antagonist Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa NK1 Receptor Antagonist Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global NK1 Receptor Antagonist Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global NK1 Receptor Antagonist Market Size by Application (2021-2026) & (US$ Million) Table 23. Global NK1 Receptor Antagonist Market Size Share by Application (2021-2026) Table 24. Global NK1 Receptor Antagonist Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global NK1 Receptor Antagonist Market Size Share Forecasted by Application (2027-2032) Table 26. North America NK1 Receptor Antagonist Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America NK1 Receptor Antagonist Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe NK1 Receptor Antagonist Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe NK1 Receptor Antagonist Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific NK1 Receptor Antagonist Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific NK1 Receptor Antagonist Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America NK1 Receptor Antagonist Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America NK1 Receptor Antagonist Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa NK1 Receptor Antagonist Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa NK1 Receptor Antagonist Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. NK1 Receptor Antagonist Industry Trends Table 37. NK1 Receptor Antagonist Industry Drivers Table 38. NK1 Receptor Antagonist Industry Opportunities and Challenges Table 39. NK1 Receptor Antagonist Industry Restraints Table 40. Global NK1 Receptor Antagonist Revenue by Company (US$ Million) & (2021-2026) Table 41. Global NK1 Receptor Antagonist Revenue Market Share by Company (2021-2026) Table 42. Global NK1 Receptor Antagonist Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global NK1 Receptor Antagonist Key Company Headquarters & Area Served Table 44. Global NK1 Receptor Antagonist Company, Product Type & Application Table 45. Global NK1 Receptor Antagonist Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global NK1 Receptor Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Glenmark Company Information Table 49. Glenmark Business Overview Table 50. Glenmark NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Glenmark NK1 Receptor Antagonist Product Portfolio Table 52. Glenmark Recent Development Table 53. Heron Therapeutics Company Information Table 54. Heron Therapeutics Business Overview Table 55. Heron Therapeutics NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Heron Therapeutics NK1 Receptor Antagonist Product Portfolio Table 57. Heron Therapeutics Recent Development Table 58. TerSera Therapeutics Company Information Table 59. TerSera Therapeutics Business Overview Table 60. TerSera Therapeutics NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. TerSera Therapeutics NK1 Receptor Antagonist Product Portfolio Table 62. TerSera Therapeutics Recent Development Table 63. Torrent Pharmaceuticals Company Information Table 64. Torrent Pharmaceuticals Business Overview Table 65. Torrent Pharmaceuticals NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Torrent Pharmaceuticals NK1 Receptor Antagonist Product Portfolio Table 67. Torrent Pharmaceuticals Recent Development Table 68. Beijing Sihuan Pharmaceutical Company Information Table 69. Beijing Sihuan Pharmaceutical Business Overview Table 70. Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Product Portfolio Table 72. Beijing Sihuan Pharmaceutical Recent Development Table 73. Fresenius Kabi Company Information Table 74. Fresenius Kabi Business Overview Table 75. Fresenius Kabi NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Fresenius Kabi NK1 Receptor Antagonist Product Portfolio Table 77. Fresenius Kabi Recent Development Table 78. Hansoh Pharma Company Information Table 79. Hansoh Pharma Business Overview Table 80. Hansoh Pharma NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Hansoh Pharma NK1 Receptor Antagonist Product Portfolio Table 82. Hansoh Pharma Recent Development Table 83. Helsinn Healthcare Company Information Table 84. Helsinn Healthcare Business Overview Table 85. Helsinn Healthcare NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Helsinn Healthcare NK1 Receptor Antagonist Product Portfolio Table 87. Helsinn Healthcare Recent Development Table 88. Jiangsu Hengrui Pharmaceuticals Company Information Table 89. Jiangsu Hengrui Pharmaceuticals Business Overview Table 90. Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Product Portfolio Table 92. Jiangsu Hengrui Pharmaceuticals Recent Development Table 93. Luoxin Pharmaceutical Company Information Table 94. Luoxin Pharmaceutical Business Overview Table 95. Luoxin Pharmaceutical NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Luoxin Pharmaceutical NK1 Receptor Antagonist Product Portfolio Table 97. Luoxin Pharmaceutical Recent Development Table 98. Merck Company Information Table 99. Merck Business Overview Table 100. Merck NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Merck NK1 Receptor Antagonist Product Portfolio Table 102. Merck Recent Development Table 103. Qilu Pharmaceutical Company Information Table 104. Qilu Pharmaceutical Business Overview Table 105. Qilu Pharmaceutical NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Qilu Pharmaceutical NK1 Receptor Antagonist Product Portfolio Table 107. Qilu Pharmaceutical Recent Development Table 108. Yichang Humanwell Pharmaceutical Company Information Table 109. Yichang Humanwell Pharmaceutical Business Overview Table 110. Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Product Portfolio Table 112. Yichang Humanwell Pharmaceutical Recent Development Table 113. Chia Tai Tianqing Pharmaceutical Company Information Table 114. Chia Tai Tianqing Pharmaceutical Business Overview Table 115. Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Product Portfolio Table 117. Chia Tai Tianqing Pharmaceutical Recent Development Table 118. North America NK1 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America NK1 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 120. North America NK1 Receptor Antagonist Market Share by Country (2021-2026) Table 121. North America NK1 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America NK1 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 123. Europe NK1 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe NK1 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe NK1 Receptor Antagonist Market Share by Country (2021-2026) Table 126. Europe NK1 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe NK1 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific NK1 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific NK1 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific NK1 Receptor Antagonist Market Share by Country (2021-2026) Table 131. Asia-Pacific NK1 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific NK1 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 133. Latin America NK1 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America NK1 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America NK1 Receptor Antagonist Market Share by Country (2021-2026) Table 136. Latin America NK1 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America NK1 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa NK1 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa NK1 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa NK1 Receptor Antagonist Market Share by Country (2021-2026) Table 141. Middle East & Africa NK1 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa NK1 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. NK1 Receptor Antagonist Product Image Figure 3. Global NK1 Receptor Antagonist Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global NK1 Receptor Antagonist Market Size (2021-2032) & (US$ Million) Figure 5. Global NK1 Receptor Antagonist Market Share by Region: 2025 VS 2032 Figure 6. Global NK1 Receptor Antagonist Market Share by Region (2021-2032) Figure 7. North America NK1 Receptor Antagonist Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe NK1 Receptor Antagonist Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific NK1 Receptor Antagonist Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America NK1 Receptor Antagonist Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa NK1 Receptor Antagonist Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Netupitant Image Figure 13. Global Netupitant Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Maropitant Image Figure 15. Global Maropitant Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Rolapitant Image Figure 17. Global Rolapitant Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Fosaprepitant Image Figure 19. Global Fosaprepitant Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Aprepitant Image Figure 21. Global Aprepitant Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Other Image Figure 23. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global NK1 Receptor Antagonist Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global NK1 Receptor Antagonist Market Share by Type 2025 VS 2032 Figure 26. North America NK1 Receptor Antagonist Market Size Share by Type (2021-2032) Figure 27. Europe NK1 Receptor Antagonist Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific NK1 Receptor Antagonist Market Size Share by Type (2021-2032) Figure 29. Latin America NK1 Receptor Antagonist Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa NK1 Receptor Antagonist Market Size Share by Type (2021-2032) Figure 31. Hospital Image Figure 32. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Specialty Clinic Image Figure 34. Global Specialty Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global NK1 Receptor Antagonist Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global NK1 Receptor Antagonist Market Share by Application 2025 VS 2032 Figure 37. North America NK1 Receptor Antagonist Market Size Share by Application (2021-2032) Figure 38. Europe NK1 Receptor Antagonist Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific NK1 Receptor Antagonist Market Size Share by Application (2021-2032) Figure 40. Latin America NK1 Receptor Antagonist Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa NK1 Receptor Antagonist Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 NK1 Receptor Antagonist Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America NK1 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America NK1 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America NK1 Receptor Antagonist Market Share by Country (2021-2032) Figure 47. Europe NK1 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe NK1 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe NK1 Receptor Antagonist Market Share by Country (2021-2032) Figure 50. Asia-Pacific NK1 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific NK1 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific NK1 Receptor Antagonist Market Share by Country (2021-2032) Figure 53. Latin America NK1 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America NK1 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America NK1 Receptor Antagonist Market Share by Country (2021-2032) Figure 56. Middle East & Africa NK1 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa NK1 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa NK1 Receptor Antagonist Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Netupitant
  • Maropitant
  • Rolapitant
  • Fosaprepitant
  • Aprepitant
  • Other
Applications
  • Hospital
  • Specialty Clinic
Companies covered
  • Glenmark
  • Heron Therapeutics
  • TerSera Therapeutics
  • Torrent Pharmaceuticals
  • Beijing Sihuan Pharmaceutical
  • Fresenius Kabi
  • Hansoh Pharma
  • Helsinn Healthcare
  • Jiangsu Hengrui Pharmaceuticals
  • Luoxin Pharmaceutical
  • Merck
  • Qilu Pharmaceutical
  • Yichang Humanwell Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global NK1 Receptor Antagonist Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global NK1 Receptor Antagonist Market Size by Region (2021-2032)
  5. 1.4.1 Global NK1 Receptor Antagonist Market Size by Region (2021-2026)
  6. 1.4.2 Global NK1 Receptor Antagonist Market Size by Region (2027-2032)
  7. 1.5 Key Regions NK1 Receptor Antagonist Market Size (2021-2032)
  8. 1.5.1 North America NK1 Receptor Antagonist Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe NK1 Receptor Antagonist Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific NK1 Receptor Antagonist Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America NK1 Receptor Antagonist Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa NK1 Receptor Antagonist Market Size Growth Rate (2021-2032)
2 NK1 Receptor Antagonist Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Netupitant
  3. 2.1.2 Maropitant
  4. 2.1.3 Rolapitant
  5. 2.1.4 Fosaprepitant
  6. 2.1.5 Aprepitant
  7. 2.1.6 Other
  8. 2.2 Global NK1 Receptor Antagonist Market Size by Type
  9. 2.2.1 Global NK1 Receptor Antagonist Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global NK1 Receptor Antagonist Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global NK1 Receptor Antagonist Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global NK1 Receptor Antagonist Market Size by Regions
  13. 2.3.1 North America NK1 Receptor Antagonist Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe NK1 Receptor Antagonist Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific NK1 Receptor Antagonist Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America NK1 Receptor Antagonist Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa NK1 Receptor Antagonist Market Size Breakdown by Type (2021-2026)
3 NK1 Receptor Antagonist Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Specialty Clinic
  4. 3.2 Global NK1 Receptor Antagonist Market Size by Application
  5. 3.2.1 Global NK1 Receptor Antagonist Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global NK1 Receptor Antagonist Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global NK1 Receptor Antagonist Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global NK1 Receptor Antagonist Market Size by Regions
  9. 3.3.1 North America NK1 Receptor Antagonist Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe NK1 Receptor Antagonist Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific NK1 Receptor Antagonist Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America NK1 Receptor Antagonist Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa NK1 Receptor Antagonist Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 NK1 Receptor Antagonist Industry Trends
  2. 4.2 NK1 Receptor Antagonist Industry Drivers
  3. 4.3 NK1 Receptor Antagonist Industry Opportunities and Challenges
  4. 4.4 NK1 Receptor Antagonist Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by NK1 Receptor Antagonist Revenue (2021-2026)
  2. 5.2 Global NK1 Receptor Antagonist Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global NK1 Receptor Antagonist Key Company Headquarters & Area Served
  4. 5.4 Global NK1 Receptor Antagonist Company, Product Type & Application
  5. 5.5 Global NK1 Receptor Antagonist Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global NK1 Receptor Antagonist Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 NK1 Receptor Antagonist Players Market Share by Revenue in 2025
  9. 5.6.3 2025 NK1 Receptor Antagonist Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Glenmark
  2. 6.1.1 Glenmark Company Information
  3. 6.1.2 Glenmark Business Overview
  4. 6.1.3 Glenmark NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Glenmark NK1 Receptor Antagonist Product Portfolio
  6. 6.1.5 Glenmark Recent Developments
  7. 6.2 Heron Therapeutics
  8. 6.2.1 Heron Therapeutics Company Information
  9. 6.2.2 Heron Therapeutics Business Overview
  10. 6.2.3 Heron Therapeutics NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Heron Therapeutics NK1 Receptor Antagonist Product Portfolio
  12. 6.2.5 Heron Therapeutics Recent Developments
  13. 6.3 TerSera Therapeutics
  14. 6.3.1 TerSera Therapeutics Company Information
  15. 6.3.2 TerSera Therapeutics Business Overview
  16. 6.3.3 TerSera Therapeutics NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 TerSera Therapeutics NK1 Receptor Antagonist Product Portfolio
  18. 6.3.5 TerSera Therapeutics Recent Developments
  19. 6.4 Torrent Pharmaceuticals
  20. 6.4.1 Torrent Pharmaceuticals Company Information
  21. 6.4.2 Torrent Pharmaceuticals Business Overview
  22. 6.4.3 Torrent Pharmaceuticals NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Torrent Pharmaceuticals NK1 Receptor Antagonist Product Portfolio
  24. 6.4.5 Torrent Pharmaceuticals Recent Developments
  25. 6.5 Beijing Sihuan Pharmaceutical
  26. 6.5.1 Beijing Sihuan Pharmaceutical Company Information
  27. 6.5.2 Beijing Sihuan Pharmaceutical Business Overview
  28. 6.5.3 Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Product Portfolio
  30. 6.5.5 Beijing Sihuan Pharmaceutical Recent Developments
  31. 6.6 Fresenius Kabi
  32. 6.6.1 Fresenius Kabi Company Information
  33. 6.6.2 Fresenius Kabi Business Overview
  34. 6.6.3 Fresenius Kabi NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius Kabi NK1 Receptor Antagonist Product Portfolio
  36. 6.6.5 Fresenius Kabi Recent Developments
  37. 6.7 Hansoh Pharma
  38. 6.7.1 Hansoh Pharma Company Information
  39. 6.7.2 Hansoh Pharma Business Overview
  40. 6.7.3 Hansoh Pharma NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Hansoh Pharma NK1 Receptor Antagonist Product Portfolio
  42. 6.7.5 Hansoh Pharma Recent Developments
  43. 6.8 Helsinn Healthcare
  44. 6.8.1 Helsinn Healthcare Company Information
  45. 6.8.2 Helsinn Healthcare Business Overview
  46. 6.8.3 Helsinn Healthcare NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Helsinn Healthcare NK1 Receptor Antagonist Product Portfolio
  48. 6.8.5 Helsinn Healthcare Recent Developments
  49. 6.9 Jiangsu Hengrui Pharmaceuticals
  50. 6.9.1 Jiangsu Hengrui Pharmaceuticals Company Information
  51. 6.9.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  52. 6.9.3 Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Product Portfolio
  54. 6.9.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  55. 6.10 Luoxin Pharmaceutical
  56. 6.10.1 Luoxin Pharmaceutical Company Information
  57. 6.10.2 Luoxin Pharmaceutical Business Overview
  58. 6.10.3 Luoxin Pharmaceutical NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Luoxin Pharmaceutical NK1 Receptor Antagonist Product Portfolio
  60. 6.10.5 Luoxin Pharmaceutical Recent Developments
  61. 6.11 Merck
  62. 6.11.1 Merck Company Information
  63. 6.11.2 Merck Business Overview
  64. 6.11.3 Merck NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Merck NK1 Receptor Antagonist Product Portfolio
  66. 6.11.5 Merck Recent Developments
  67. 6.12 Qilu Pharmaceutical
  68. 6.12.1 Qilu Pharmaceutical Company Information
  69. 6.12.2 Qilu Pharmaceutical Business Overview
  70. 6.12.3 Qilu Pharmaceutical NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Qilu Pharmaceutical NK1 Receptor Antagonist Product Portfolio
  72. 6.12.5 Qilu Pharmaceutical Recent Developments
  73. 6.13 Yichang Humanwell Pharmaceutical
  74. 6.13.1 Yichang Humanwell Pharmaceutical Company Information
  75. 6.13.2 Yichang Humanwell Pharmaceutical Business Overview
  76. 6.13.3 Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Product Portfolio
  78. 6.13.5 Yichang Humanwell Pharmaceutical Recent Developments
  79. 6.14 Chia Tai Tianqing Pharmaceutical
  80. 6.14.1 Chia Tai Tianqing Pharmaceutical Company Information
  81. 6.14.2 Chia Tai Tianqing Pharmaceutical Business Overview
  82. 6.14.3 Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Product Portfolio
  84. 6.14.5 Chia Tai Tianqing Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America NK1 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America NK1 Receptor Antagonist Market Size by Country (2021-2026)
  3. 7.3 North America NK1 Receptor Antagonist Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe NK1 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe NK1 Receptor Antagonist Market Size by Country (2021-2026)
  3. 8.3 Europe NK1 Receptor Antagonist Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific NK1 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific NK1 Receptor Antagonist Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific NK1 Receptor Antagonist Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America NK1 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America NK1 Receptor Antagonist Market Size by Country (2021-2026)
  3. 10.3 South America NK1 Receptor Antagonist Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa NK1 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa NK1 Receptor Antagonist Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa NK1 Receptor Antagonist Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst